Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 2
Submit an article Journal homepage
849
Views
12
CrossRef citations to date
0
Altmetric
Research Article

The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide

Tzu-Fei WangDivision of Oncology, Department of Medicine
,
Rohan AhluwaliaDepartment of Medicine
,
Mark A. FialaDivision of Oncology, Department of Medicine
,
Kathryn M. TrinkausDivision of Biostatistics, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA
,
Doug P. CoxDivision of Oncology, Department of Medicine
,
Matthew JaenickeDivision of Oncology, Department of Medicine
,
Caitlin C. MoliskeDivision of Oncology, Department of Medicine
,
Kenneth R. CarsonDivision of Oncology, Department of Medicine
,
Tanya M. WildesDivision of Oncology, Department of Medicine
,
Michael H. TomassonDivision of Oncology, Department of Medicine
,
Keith E. Stockerl-GoldsteinDivision of Oncology, Department of Medicine
&
Ravi VijDivision of Oncology, Department of MedicineCorrespondence[email protected]
 show all
Pages 337-341 | Received 12 Feb 2013, Accepted 06 May 2013, Published online: 24 Jun 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Antonio Palumbo & Pieter Sonneveld. (2015) Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma. Expert Review of Hematology 8:4, pages 481-491.
Read now

Articles from other publishers (11)

Reham Ashour, Masaki Ri, Sanaa Shaker Aly, Takashi Yoshida, Takuto Tachita, Takashi Kanamori, Sho Aoki, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Hirokazu Komatsu, Samar Mansour, Abdelrahman A. Elsaied & Shinsuke Iida. (2019) Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma. International Journal of Hematology 110:1, pages 69-76.
Crossref
Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev & K.D. Kaplanov. (2019) Practical Aspects of the Use of Carfilzomib in Multiple Myeloma. Clinical oncohematology 12:1, pages 21-31.
Crossref
Joshua Richter, Noa Biran, Narjust Duma, David H. Vesole & David Siegel. (2017) Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series. Hematological Oncology 35:2, pages 246-251.
Crossref
Leo Rasche, Christoph Röllig, Gernot Stuhler, Sophia Danhof, Stephan Mielke, Goetz Ulrich Grigoleit, Lea Dissen, Lea Schemmel, Jan Moritz Middeke, Viktoria Rücker, Martin Schreder, Johannes Schetelig, Martin Bornhäuser, Hermann Einsele, Christian Thiede & Stefan Knop. (2016) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features. Biology of Blood and Marrow Transplantation 22:11, pages 1988-1996.
Crossref
Leo Rasche, Emmanuelle Menoret, Valentina Dubljevic, Eline Menu, Karin Vanderkerken, Constantin Lapa, Torsten Steinbrunn, Manik Chatterjee, Stefan Knop, Johannes Düll, Deanne L. Greenwood, Frank Hensel, Andreas Rosenwald, Hermann Einsele & Stephanie Brändlein. (2016) A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement. Clinical Cancer Research 22:17, pages 4341-4349.
Crossref
Eli Muchtar, Morie A. Gertz & Hila Magen. (2016) A practical review on carfilzomib in multiple myeloma. European Journal of Haematology 96:6, pages 564-577.
Crossref
Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson & Monica Shokeen. (2016) Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents. Journal of Nuclear Medicine 57:4, pages 640-645.
Crossref
Ravi Vij, Kathryn J. Fowler & Monica Shokeen. (2016) New Approaches to Molecular Imaging of Multiple Myeloma. Journal of Nuclear Medicine 57:1, pages 1-4.
Crossref
Tatsuo Ichinohe, Yoshiaki Kuroda, Shinichiro Okamoto, Kosei Matsue, Shinsuke Iida, Kazutaka Sunami, Takuya Komeno, Kenshi Suzuki, Kiyoshi Ando, Masafumi Taniwaki, Kensei Tobinai, Takaaki Chou, Hitomi Kaneko, Hiromi Iwasaki, Chie Uemura, Hiromi Tamakoshi, Mohamed H. Zaki, Thomas Doerr & Shotaro Hagiwara. (2016) A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial. Experimental Hematology & Oncology 5:1.
Crossref
Hyo Jung Kim. (2015) Novel Agents for Treatment of Multiple Myeloma. Korean Journal of Medicine 88:3, pages 252.
Crossref
Krzysztof Jamroziak, Ewa Wawrzyniak & El?bieta Iskierka. (2014) Znaczenie bortezomibu w leczeniu szpiczaka plazmocytowego u pacjent?w z ryzykiem cytogenetycznym. Acta Haematologica Polonica 45:3, pages 247-257.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.